How does red light therapy work? - Red Light Hero

How does red light therapy work?

First published
Last reviewed
Reading time
4 min read

In short

Red and near-infrared light is absorbed by an enzyme in the mitochondria, cytochrome c oxidase, and that is where everything else starts: more cellular energy, measured in cells and in people's forearms. Red reaches the skin, near-infrared reaches deeper, and the dose follows a curve - too little does nothing, too much undoes the gain.

That is why our panels carry both bands, run continuously, and come with a dosage estimator rather than a "more is better" sales pitch.

Key takeaways

  1. Red and near-infrared light is absorbed by cytochrome c oxidase, an enzyme in the mitochondria - that is where the effect starts.Read this section: Where the light goes
  2. In muscle cells a 90-second dose of 630 and 850nm LED light raised ATP, peaking three to six hours later; in people, 810nm LED on the forearm raised the oxidised form of the enzyme and blood oxygenation.Read this section: What happens in the mitochondria
  3. Red is absorbed mostly in the skin and near-infrared reaches deeper tissue, which is why panels carry both and skip the colours that only reach the surface.Read this section: Why red and near-infrared, and not green
  4. The dose response is biphasic: nothing below a threshold, a plateau, then a decline - so a longer session is not a stronger session.Read this section: More is not better
  5. In two dose-escalation trials, red LED light on skin was safe up to 320-480 J/cm², many times a normal session.Read this section: Is it safe?

Red light therapy is simple to describe: red and near-infrared light shone on the skin for a few minutes at a time. What it does once it gets there is a cell-level story, and most of it happens in the mitochondria. This post is the short version of our How RLT Works page, with the studies linked as we go.

Where the light goes

Light only does something if a molecule absorbs it. The one that matters here is cytochrome c oxidase, an enzyme in the mitochondria that sits at the end of the chain that makes ATP, the cell's energy currency. The NASA LED research group described this twenty years ago: red to near-infrared light (630-1000nm) is absorbed by cytochrome c oxidase, and LED light increased the enzyme in cultured nerve cells. A 2018 review of the mechanism puts it the same way: the primary site of absorption in mammalian cells is the mitochondria, and more specifically cytochrome c oxidase.

What happens in the mitochondria

The working hypothesis, in that same review, is that light knocks inhibitory nitric oxide off the enzyme, restoring electron transport and raising the mitochondrial membrane potential. The word hypothesis is the authors' own - the absorption is measured, the nitric oxide step is the best current explanation of what follows.

The downstream part has been measured directly. In mouse muscle cells, a 90-second dose from a 630 and 850nm LED cluster at 28 mW/cm² raised membrane potential and ATP, peaking three to six hours after the light - cells in a dish, so it shows the mechanism rather than a benefit in a person. In people, a 2022 study shone 810nm LED light on the forearm and measured, through the skin, a rise in oxidised cytochrome c oxidase and in oxygenated haemoglobin. That is the enzyme responding in a living arm. Our ATP research page lists these and the rest wavelength by wavelength.

Why red and near-infrared, and not green

Two reasons. First, the research clusters there: most of the promising results sit roughly in the 600-700nm and 800-900nm bands, which is why panels use the wavelengths they do. Second, the two bands reach different depths. Red is absorbed mostly in the skin and near-infrared penetrates further, and a 2020 review of multi-wavelength photobiomodulation concluded that combining them can present a therapeutic advantage by providing concurrent energy delivery to biological tissues at different depths. Blue is a different question with a different answer, which we wrote up in why our panels have no blue light.

Why not just sit in the sun

Sunlight contains the red and near-infrared bands, and a lot else: ultraviolet, with its well-known costs, and more blue than you want in the evening. The How RLT Works page has the colour-by-colour table. Two more practical problems: clothes cover most of the skin whenever we are outside, and cities are short of near-infrared because built surfaces absorb it while plants and other greenery reflect it. A panel gives you the two useful bands, nothing else, on as much skin as you choose to expose.

More is not better

The dose response is biphasic. Below a threshold nothing happens; above it there is a plateau; push further and the effect falls away again - Huang, Chen, Carroll and Hamblin set this out in 2009 and updated it in 2011. So a longer session is not a stronger session, and a panel that flickers or pulses is delivering less than it looks like it is, which is the point of our flicker test and pulsing posts. For session times, the Dosage Estimator turns your panel and your distance from it into minutes for each goal, and How to do RLT covers the routine.

Is it safe?

For skin, the best data are two phase I dose-escalation trials of red LED light in healthy adults, which found it safe up to 320 J/cm² for skin of colour and 480 J/cm² for non-Hispanic Caucasian participants; the dose-limiting effects at the top of the range were blistering and prolonged redness, and no serious adverse events occurred. A normal panel session is a small fraction of those doses. Eyes are a separate question, covered in our eyesight post. Our devices are not medical devices and are not intended to treat or prevent disease; the disclaimer at the bottom of every post says so for a reason.

Where to go next

If you want to know which device fits what you want to do, the device finder asks six questions and answers that. If you want the studies themselves, start with the wavelength research page. And if you want to ask a person, contact us - Helmut answers himself.

References

Our sources for this article along with direct links and the reason we chose to cite it.

  1. Eells et al. (2004). Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. MitochondrionWhy we cite it: The NASA LED group's paper identifying cytochrome c oxidase as the molecule that absorbs red and near-infrared light; the basis of the "where the light goes" section.
  2. Hamblin (2018). Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochemistry and PhotobiologyWhy we cite it: The review of the mechanism: absorption by cytochrome c oxidase, the nitric oxide hypothesis and the rise in membrane potential. It is where the word "hypothesis" comes from.
  3. Ferraresi et al. (2015). Low-level laser (light) therapy increases mitochondrial membrane potential and ATP synthesis in C2C12 myotubes with a peak response at 3-6 hours. Photochemistry and PhotobiologyWhy we cite it: The cell study behind the ATP timing claim: mouse muscle cells, a 630 and 850nm LED cluster at 28 mW/cm² for 90 seconds. Cells in a dish, not people.
  4. Pruitt et al. (2022). Photobiomodulation at different wavelengths boosts mitochondrial redox metabolism and hemoglobin oxygenation: lasers vs light-emitting diodes in vivo. MetabolitesWhy we cite it: The human forearm study in which 810nm LED light raised oxidised cytochrome c oxidase and oxygenated haemoglobin, measured through the skin.
  5. Lima, Sergio and da Fonseca (2020). Photobiomodulation via multiple-wavelength radiations. Lasers in Medical ScienceWhy we cite it: The review of combined-wavelength photobiomodulation quoted on different tissue depths; a review, not a trial.
  6. Huang, Chen, Carroll and Hamblin (2009). Biphasic dose response in low level light therapy. Dose-ResponseWhy we cite it: The paper that set out the biphasic dose response: threshold, plateau, decline.
  7. Huang, Sharma, Carroll and Hamblin (2011). Biphasic dose response in low level light therapy - an update. Dose-ResponseWhy we cite it: The 2011 update of the same work, cited alongside the original.
  8. Jagdeo et al. (2019). Safety of light emitting diode-red light on human skin: two randomized controlled trials. Journal of BiophotonicsWhy we cite it: The two phase I dose-escalation trials (STARS 1 and 2) that set a maximum tolerated dose of red LED light on skin; the safety section rests on them.
  9. University of New Hampshire (2021). Seeing infraredWhy we cite it: A university article on plants reflecting near-infrared, the source for the line about greenery and cities.

About the author

Helmut Uhlmann

Helmut Uhlmann

Founder, Red Light Hero

Helmut Uhlmann founded Red Light Hero and writes this blog. He delves deep into the research and is passionate about helping people get the most out of red light therapy.

Our story

Speak to us

Questions about this article, or about which device fits what you want to do? Email us or leave a comment. Advice is complimentary and there is no obligation to buy anything.

Disclaimer

Red Light Hero devices use clinical-grade LEDs but are not included in the ARTG and are not intended to treat or prevent disease. The research discussed here is about the wavelengths and technologies we use, not about our products. This article is educational information only, not medical advice - check with your healthcare professional before use, particularly if you are pregnant, take medication that increases light sensitivity, or have a condition affecting your eyes or skin.

Leave a comment

Please note, comments need to be approved before they are published.

Back to blog